A Phase III Study of Durvalumab (MEDI4736) With or Without Tremelimumab for Previously Treated Patients With Advanced NSCLC: Rationale and Protocol Design of the ARCTIC Study

• Published in: Clinical Lung Cancer
• Main Authors: Planchard, David, Yokoi, Takashi, McCleod, Michael J., Fischer, Jürgen R., Kim, Young-Chul, Ballas, Marc, Shi, Kelvin, Soria, Jean-Charles
• Format: Article in Journal/Newspaper
• Language: English
• Published: Elsevier BV 2016
• Subjects: Cancer Research; Pulmonary and Respiratory Medicine; Oncology; Arctic
• Online Access: http://dx.doi.org/10.1016/j.cllc.2016.03.003; https://api.elsevier.com/content/article/PII:S1525730416300328?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S1525730416300328?httpAccept=text/plain